Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CarryGenes Therapeutics AB
AB
Active
Org 5591464689
Rörstrandsgatan 58, 113 40
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2018
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
CarryGenes Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
SL
Sven Lennart Dreyer
Chief Executive Officer
Chief Executive Officer
2022
SJ
Sten Johan Pharmanson
Chief Auditor
Chief Auditor
2024
Former (2)
TD
Thijs Dirkse
Chief Auditor
Chief Auditor
2020 – 2024
SO
Stig Ola Winqvist
Chief Executive Officer
Chief Executive Officer
2023 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
DG
Derek Gregory Batcheller
Chairman
2023
SJ
Stig Jonas Winqvist
Board of Directors
2022
MS
Michael Sven Rohmann
Board of Directors
2020
Former (7)
UL
Ulf Lennart Holm
Board of Directors
2020 – 2024
HO
Hans Olof Glise
Chairman
2020 – 2022
NJ
Nils Jan Ragnar Nilsson
Board of Directors
2020 – 2024
FN
Fredrik Nielsen
Board of Directors
2024 – 2024
DG
Derek Gregory Batcheller
Chairman
2022 – 2023
LS
Lars-Gunnar Stefan Appelgren
Board of Directors
2023 – 2023
OP
Olle Per Gösta Larson
Board of Directors
2020 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on CarryGenes Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network